The Cigna Group
CI
$344.50
-$12.68-3.55%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | 182.65B | 177.47B | 174.17B | 171.62B | 169.64B |
Total Other Revenue | 12.54B | 12.39B | 11.86B | 11.19B | 10.39B |
Total Revenue | 195.19B | 189.87B | 186.03B | 182.81B | 180.03B |
Cost of Revenue | 170.09B | 165.61B | 162.57B | 159.44B | 157.02B |
Gross Profit | 25.10B | 24.26B | 23.46B | 23.37B | 23.01B |
SG&A Expenses | 14.37B | 14.05B | 13.61B | 13.42B | 13.11B |
Depreciation & Amortization | 1.82B | 1.83B | 1.83B | 1.88B | 1.88B |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 186.28B | 181.49B | 178.01B | 174.74B | 172.00B |
Operating Income | 8.91B | 8.38B | 8.02B | 8.07B | 8.03B |
Income Before Tax | 5.51B | 6.68B | 8.33B | 8.43B | 8.40B |
Income Tax Expenses | 141.00M | 1.20B | 1.52B | 1.56B | 1.62B |
Earnings from Continuing Operations | 5.37K | 5.49K | 6.82K | 6.88K | 6.78K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -208.00M | -159.00M | -139.00M | -102.00M | -78.00M |
Net Income | 5.16B | 5.33B | 6.68B | 6.77B | 6.70B |
EBIT | 8.91B | 8.38B | 8.02B | 8.07B | 8.03B |
EBITDA | 11.95B | 11.39B | 10.98B | 11.04B | 10.96B |
EPS Basic | 17.52 | 17.94 | 22.22 | 22.21 | 21.68 |
Normalized Basic EPS | 15.22 | 14.25 | 13.57 | 13.67 | 13.55 |
EPS Diluted | 17.39 | 17.80 | 22.03 | 22.00 | 21.49 |
Normalized Diluted EPS | 15.11 | 14.14 | 13.46 | 13.56 | 13.44 |
Average Basic Shares Outstanding | 1.18B | 1.19B | 1.20B | 1.22B | 1.24B |
Average Diluted Shares Outstanding | 1.19B | 1.20B | 1.21B | 1.23B | 1.25B |
Dividend Per Share | 4.92 | 4.81 | 4.70 | 4.59 | 4.48 |
Payout Ratio | 28.08% | 26.76% | 21.04% | 20.59% | 20.64% |